 | • レポートコード：QAF27875 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の呼吸器用治療薬市場について種類別（吸入・点鼻薬、経口、その他）、用途別（病院、ドラッグストア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・呼吸器用治療薬市場の概要 ・世界の主要地域別呼吸器用治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の呼吸器用治療薬市場規模2016-2021：種類別（吸入・点鼻薬、経口、その他） ・世界の呼吸器用治療薬市場予測2012-2027：種類別（吸入・点鼻薬、経口、その他） ・世界の呼吸器用治療薬市場規模2016-2021：用途別（病院、ドラッグストア） ・世界の呼吸器用治療薬市場予測2012-2027：用途別（病院、ドラッグストア） ・呼吸器用治療薬のアメリカ市場規模と予測2016-2021 ・呼吸器用治療薬のヨーロッパ市場規模と予測2016-2021 ・呼吸器用治療薬の中国市場規模と予測2016-2021 ・呼吸器用治療薬の日本市場規模と予測2016-2021 ・呼吸器用治療薬の東南アジア市場規模と予測2016-2021 ・呼吸器用治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、AstraZeneca、Boehringer Ingelheim、Vertex、Roche、Novartis、Teva、Chiesi、Mylan、Sumitomo Dainippon、Merck、Beximco） ・呼吸器用治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・呼吸器用治療薬の市場動向・機会・課題 ・調査の結論 |
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
Market Analysis and Insights: Global Respiratory Drug Market
The global Respiratory Drug market was valued at US$ 43040 in 2020 and will reach US$ 60360 million by the end of 2027, growing at a CAGR of 5.8% during 2022-2027.
Global Respiratory Drug Scope and Market Size
The global Respiratory Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
The Respiratory Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Respiratory Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
1 Respiratory Drug Market Overview
1.1 Respiratory Drug Product Scope
1.2 Respiratory Drug Segment by Type
1.2.1 Global Respiratory Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Respiratory Drug Segment by Application
1.3.1 Global Respiratory Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Respiratory Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Respiratory Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Respiratory Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Respiratory Drug Price Trends (2016-2027)
2 Respiratory Drug Estimates and Forecasts by Region
2.1 Global Respiratory Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Respiratory Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Respiratory Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Respiratory Drug Revenue Market Share by Region (2016-2021)
2.3 Global Respiratory Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Respiratory Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Respiratory Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Respiratory Drug Estimates and Projections (2016-2027)
2.4.2 Europe Respiratory Drug Estimates and Projections (2016-2027)
2.4.3 China Respiratory Drug Estimates and Projections (2016-2027)
2.4.4 Japan Respiratory Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Respiratory Drug Estimates and Projections (2016-2027)
2.4.6 India Respiratory Drug Estimates and Projections (2016-2027)
3 Global Respiratory Drug Competition Landscape by Players
3.1 Global Top Respiratory Drug Players by Sales (2016-2021)
3.2 Global Top Respiratory Drug Players by Revenue (2016-2021)
3.3 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Drug as of 2020)
3.4 Global Respiratory Drug Average Price by Company (2016-2021)
3.5 Manufacturers Respiratory Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Respiratory Drug Market Size by Type
4.1 Global Respiratory Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Respiratory Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Respiratory Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Respiratory Drug Price by Type (2016-2021)
4.2 Global Respiratory Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Respiratory Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Respiratory Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Respiratory Drug Price Forecast by Type (2022-2027)
5 Global Respiratory Drug Market Size by Application
5.1 Global Respiratory Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Respiratory Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Respiratory Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Respiratory Drug Price by Application (2016-2021)
5.2 Global Respiratory Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Respiratory Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Respiratory Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Respiratory Drug Price Forecast by Application (2022-2027)
6 North America Respiratory Drug Market Facts & Figures
6.1 North America Respiratory Drug Sales by Company
6.1.1 North America Respiratory Drug Sales by Company (2016-2021)
6.1.2 North America Respiratory Drug Revenue by Company (2016-2021)
6.2 North America Respiratory Drug Sales Breakdown by Type
6.2.1 North America Respiratory Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Respiratory Drug Sales Breakdown by Type (2022-2027)
6.3 North America Respiratory Drug Sales Breakdown by Application
6.3.1 North America Respiratory Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Respiratory Drug Sales Breakdown by Application (2022-2027)
7 Europe Respiratory Drug Market Facts & Figures
7.1 Europe Respiratory Drug Sales by Company
7.1.1 Europe Respiratory Drug Sales by Company (2016-2021)
7.1.2 Europe Respiratory Drug Revenue by Company (2016-2021)
7.2 Europe Respiratory Drug Sales Breakdown by Type
7.2.1 Europe Respiratory Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Respiratory Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Respiratory Drug Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Respiratory Drug Market Facts & Figures
8.1 China Respiratory Drug Sales by Company
8.1.1 China Respiratory Drug Sales by Company (2016-2021)
8.1.2 China Respiratory Drug Revenue by Company (2016-2021)
8.2 China Respiratory Drug Sales Breakdown by Type
8.2.1 China Respiratory Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Respiratory Drug Sales Breakdown by Type (2022-2027)
8.3 China Respiratory Drug Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Respiratory Drug Market Facts & Figures
9.1 Japan Respiratory Drug Sales by Company
9.1.1 Japan Respiratory Drug Sales by Company (2016-2021)
9.1.2 Japan Respiratory Drug Revenue by Company (2016-2021)
9.2 Japan Respiratory Drug Sales Breakdown by Type
9.2.1 Japan Respiratory Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Respiratory Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Respiratory Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Respiratory Drug Market Facts & Figures
10.1 Southeast Asia Respiratory Drug Sales by Company
10.1.1 Southeast Asia Respiratory Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Respiratory Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Respiratory Drug Sales Breakdown by Type
10.2.1 Southeast Asia Respiratory Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Respiratory Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Respiratory Drug Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Respiratory Drug Market Facts & Figures
11.1 India Respiratory Drug Sales by Company
11.1.1 India Respiratory Drug Sales by Company (2016-2021)
11.1.2 India Respiratory Drug Revenue by Company (2016-2021)
11.2 India Respiratory Drug Sales Breakdown by Type
11.2.1 India Respiratory Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Respiratory Drug Sales Breakdown by Type (2022-2027)
11.3 India Respiratory Drug Sales Breakdown by Application
11.3.1 India Respiratory Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Respiratory Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Respiratory Drug Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Respiratory Drug Products Offered
12.1.5 GSK Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Respiratory Drug Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Respiratory Drug Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Vertex
12.4.1 Vertex Corporation Information
12.4.2 Vertex Business Overview
12.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Vertex Respiratory Drug Products Offered
12.4.5 Vertex Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Business Overview
12.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Respiratory Drug Products Offered
12.5.5 Roche Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Respiratory Drug Products Offered
12.6.5 Novartis Recent Development
12.7 Teva
12.7.1 Teva Corporation Information
12.7.2 Teva Business Overview
12.7.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Respiratory Drug Products Offered
12.7.5 Teva Recent Development
12.8 Chiesi
12.8.1 Chiesi Corporation Information
12.8.2 Chiesi Business Overview
12.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chiesi Respiratory Drug Products Offered
12.8.5 Chiesi Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Business Overview
12.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Respiratory Drug Products Offered
12.9.5 Mylan Recent Development
12.10 Sumitomo Dainippon
12.10.1 Sumitomo Dainippon Corporation Information
12.10.2 Sumitomo Dainippon Business Overview
12.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sumitomo Dainippon Respiratory Drug Products Offered
12.10.5 Sumitomo Dainippon Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Business Overview
12.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Respiratory Drug Products Offered
12.11.5 Merck Recent Development
12.12 Beximco
12.12.1 Beximco Corporation Information
12.12.2 Beximco Business Overview
12.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Beximco Respiratory Drug Products Offered
12.12.5 Beximco Recent Development
13 Respiratory Drug Manufacturing Cost Analysis
13.1 Respiratory Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Respiratory Drug
13.4 Respiratory Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Respiratory Drug Distributors List
14.3 Respiratory Drug Customers
15 Market Dynamics
15.1 Respiratory Drug Market Trends
15.2 Respiratory Drug Drivers
15.3 Respiratory Drug Market Challenges
15.4 Respiratory Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Respiratory Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Respiratory Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Respiratory Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Respiratory Drug Sales (M Units) by Region (2016-2021)
Table 5. Global Respiratory Drug Sales Market Share by Region (2016-2021)
Table 6. Global Respiratory Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Respiratory Drug Revenue Share by Region (2016-2021)
Table 8. Global Respiratory Drug Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Respiratory Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Respiratory Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Respiratory Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Respiratory Drug Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Respiratory Drug Sales Share by Company (2016-2021)
Table 14. Global Respiratory Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Respiratory Drug Revenue Share by Company (2016-2021)
Table 16. Global Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drug as of 2020)
Table 17. Global Respiratory Drug Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Respiratory Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Respiratory Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Respiratory Drug Sales (M Units) by Type (2016-2021)
Table 22. Global Respiratory Drug Sales Share by Type (2016-2021)
Table 23. Global Respiratory Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Respiratory Drug Price (US$/Unit) by Type (2016-2021)
Table 25. Global Respiratory Drug Sales Share by Type (2022-2027)
Table 26. Global Respiratory Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Respiratory Drug Revenue Share by Type (2022-2027)
Table 28. Global Respiratory Drug Price (US$/Unit) by Type (2022-2027)
Table 29. Global Respiratory Drug Sales (M Units) by Application (2016-2021)
Table 30. Global Respiratory Drug Sales Share by Application (2016-2021)
Table 31. Global Respiratory Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Respiratory Drug Price (US$/Unit) by Application (2016-2021)
Table 33. Global Respiratory Drug Sales (M Units) by Application (2022-2027)
Table 34. Global Respiratory Drug Sales Share by Application (2022-2027)
Table 35. Global Respiratory Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Respiratory Drug Revenue Share by Application (2022-2027)
Table 37. Global Respiratory Drug Price (US$/Unit) by Application (2022-2027)
Table 38. North America Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 39. North America Respiratory Drug Sales Market Share by Company (2016-2021)
Table 40. North America Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 43. North America Respiratory Drug Sales Market Share by Type (2016-2021)
Table 44. North America Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 45. North America Respiratory Drug Sales Market Share by Type (2022-2027)
Table 46. North America Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 47. North America Respiratory Drug Sales Market Share by Application (2016-2021)
Table 48. North America Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 49. North America Respiratory Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 51. Europe Respiratory Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 55. Europe Respiratory Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 57. Europe Respiratory Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 59. Europe Respiratory Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 61. Europe Respiratory Drug Sales Market Share by Application (2022-2027)
Table 62. China Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 63. China Respiratory Drug Sales Market Share by Company (2016-2021)
Table 64. China Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 66. China Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 67. China Respiratory Drug Sales Market Share by Type (2016-2021)
Table 68. China Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 69. China Respiratory Drug Sales Market Share by Type (2022-2027)
Table 70. China Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 71. China Respiratory Drug Sales Market Share by Application (2016-2021)
Table 72. China Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 73. China Respiratory Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 75. Japan Respiratory Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 79. Japan Respiratory Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 81. Japan Respiratory Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 83. Japan Respiratory Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 85. Japan Respiratory Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Respiratory Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Respiratory Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Respiratory Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Respiratory Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Respiratory Drug Sales Market Share by Application (2022-2027)
Table 98. India Respiratory Drug Sales (M Units) by Company (2016-2021)
Table 99. India Respiratory Drug Sales Market Share by Company (2016-2021)
Table 100. India Respiratory Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Respiratory Drug Revenue Market Share by Company (2016-2021)
Table 102. India Respiratory Drug Sales by Type (2016-2021) & (M Units)
Table 103. India Respiratory Drug Sales Market Share by Type (2016-2021)
Table 104. India Respiratory Drug Sales by Type (2022-2027) & (M Units)
Table 105. India Respiratory Drug Sales Market Share by Type (2022-2027)
Table 106. India Respiratory Drug Sales by Application (2016-2021) & (M Units)
Table 107. India Respiratory Drug Sales Market Share by Application (2016-2021)
Table 108. India Respiratory Drug Sales by Application (2022-2027) & (M Units)
Table 109. India Respiratory Drug Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. GSK Respiratory Drug Product
Table 114. GSK Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. AstraZeneca Respiratory Drug Product
Table 119. AstraZeneca Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Respiratory Drug Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Vertex Corporation Information
Table 126. Vertex Description and Business Overview
Table 127. Vertex Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Vertex Respiratory Drug Product
Table 129. Vertex Recent Development
Table 130. Roche Corporation Information
Table 131. Roche Description and Business Overview
Table 132. Roche Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Roche Respiratory Drug Product
Table 134. Roche Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Novartis Respiratory Drug Product
Table 139. Novartis Recent Development
Table 140. Teva Corporation Information
Table 141. Teva Description and Business Overview
Table 142. Teva Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Teva Respiratory Drug Product
Table 144. Teva Recent Development
Table 145. Chiesi Corporation Information
Table 146. Chiesi Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Chiesi Description and Business Overview
Table 148. Chiesi Respiratory Drug Product
Table 149. Chiesi Recent Development
Table 150. Mylan Corporation Information
Table 151. Mylan Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Mylan Description and Business Overview
Table 153. Mylan Respiratory Drug Product
Table 154. Mylan Recent Development
Table 155. Sumitomo Dainippon Corporation Information
Table 156. Sumitomo Dainippon Description and Business Overview
Table 157. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Sumitomo Dainippon Respiratory Drug Product
Table 159. Sumitomo Dainippon Recent Development
Table 160. Merck Corporation Information
Table 161. Merck Description and Business Overview
Table 162. Merck Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Merck Respiratory Drug Product
Table 164. Merck Recent Development
Table 165. Beximco Corporation Information
Table 166. Beximco Description and Business Overview
Table 167. Beximco Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Beximco Respiratory Drug Product
Table 169. Beximco Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Respiratory Drug Distributors List
Table 173. Respiratory Drug Customers List
Table 174. Respiratory Drug Market Trends
Table 175. Respiratory Drug Market Drivers
Table 176. Respiratory Drug Market Challenges
Table 177. Respiratory Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Respiratory Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Drugs Store Examples
Figure 8. Global Respiratory Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Respiratory Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Respiratory Drug Sales (M Units) Growth Rate (2016-2027)
Figure 11. Global Respiratory Drug Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 12. Global Respiratory Drug Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Respiratory Drug Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Respiratory Drug Sales (M Units) Growth Rate (2016-2027)
Figure 16. Europe Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Respiratory Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Respiratory Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Respiratory Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Respiratory Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Respiratory Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Respiratory Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Respiratory Drug Players Market Share by Revenue in Respiratory Drug: 2016 & 2020
Figure 27. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Respiratory Drug Revenue Share by Type (2016-2021)
Figure 29. Global Respiratory Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Respiratory Drug Revenue Share by Application (2016-2021)
Figure 31. Global Respiratory Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Respiratory Drug Sales Market Share by Type in 2020
Figure 33. North America Respiratory Drug Sales Market Share by Application in 2020
Figure 34. Europe Respiratory Drug Sales Market Share by Type in 2020
Figure 35. Europe Respiratory Drug Sales Market Share by Application in 2020
Figure 36. China Respiratory Drug Sales Market Share by Type in 2020
Figure 37. China Respiratory Drug Sales Market Share by Application in 2020
Figure 38. Japan Respiratory Drug Sales Market Share by Type in 2020
Figure 39. Japan Respiratory Drug Sales Market Share by Application in 2020
Figure 40. Southeast Asia Respiratory Drug Sales Market Share by Type in 2020
Figure 41. Southeast Asia Respiratory Drug Sales Market Share by Application in 2020
Figure 42. India Respiratory Drug Sales Market Share by Type in 2020
Figure 43. India Respiratory Drug Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Respiratory Drug
Figure 46. Manufacturing Process Analysis of Respiratory Drug
Figure 47. Respiratory Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027. With industry-standard a…- 呼吸用保護具（RPE）のグローバル市場2021 Respiratory Protective Equipment (RPE) is a particular type of Personal Protective Equipment (PPE), used to protect the individual wearer against the inhalation of hazardous substances in the workplace air. The growth of this market is driven by the high consumption of air-purifying respirators in t…
- 世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
- 世界の牛用呼吸器ワクチン市場規模・現状・予測（2021年-2027年） Bovine respiratory vaccines for the prevention of respiratory diseases in cattle such as Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD), Parainfluenza 3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV). A variety of vaccines are available. See product details for vaccine use…
- 世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Respiratory Disease Therapeutics Market The global Pediatric Respiratory Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…